Error in Table Footnote

The Original Investigation titled “Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial,”¹ published online August 4, 2021, and in the September 2021 issue, was corrected to fix the indication of statistical variance in footnote b of Table 2. The correct term is “SE” instead of “SD.” The footnote should have read as follows: “^bLeast-squares mean (SE) [95% CI].” This article was corrected online.